-
1
-
-
34548277030
-
Survival for eight major cancers and all cancers combined for european adults diagnosed in 1995-99: Results of the eurocare-4 study
-
Berrino F, De AR, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, et al.Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-83.
-
(2007)
Lancet Oncol
, vol.8
, pp. 773-783
-
-
Berrino, F.1
De, A.R.2
Sant, M.3
Rosso, S.4
Bielska-Lasota, M.5
Coebergh, J.W.6
-
2
-
-
0003700872
-
Globocan 2002
-
Lyon: IARC Press
-
Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5, Version 2.0. Lyon: IARC Press; 2004.
-
(2004)
Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5, Version 2.0
-
-
Ferlay, J.1
Bray, F.2
Pisani, P.3
Parkin, D.M.4
-
4
-
-
0037132795
-
Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: Retrospective audit
-
Kirwan JM, Tincello DG, Herod JJ, Frost O, Kingston RE. Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit. BMJ 2002;324:148-51.
-
(2002)
BMJ
, vol.324
, pp. 148-151
-
-
Kirwan, J.M.1
Tincello, D.G.2
Herod, J.J.3
Frost, O.4
Kingston, R.E.5
-
6
-
-
0026771279
-
Serous borderline tumors of the ovary: A clinicopathologic, immunohistochemical, and quantitative study of 44 cases
-
de Nictolis M, Montironi R, Tommasoni S, Carinelli S, Ojeda B, Matias-Guiu X, et al. Serous borderline tumors of the ovary: a clinicopathologic, immunohistochemical, and quantitative study of 44 cases. Cancer 2006;70:152-60.
-
(2006)
Cancer
, vol.70
, pp. 152-160
-
-
De Nictolis, M.1
Montironi, R.2
Tommasoni, S.3
Carinelli, S.4
Ojeda, B.5
Matias-Guiu, X.6
-
8
-
-
34447526802
-
Management of ovarian germ cell tumors
-
Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol 2007;25:2938-43.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2938-2943
-
-
Gershenson, D.M.1
-
9
-
-
0023775180
-
Symptomatology of ovarian cancer
-
Flam F, Einhorn N, Sjovall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1988;27:53-7.
-
(1988)
Eur J
, vol.27
, pp. 53-57
-
-
Flam, F.1
Einhorn, N.2
Sjovall, K.3
-
10
-
-
33846245932
-
Development of an ovarian cancer symptom index: Possibilities for earlier detection
-
Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007;109:221-7.
-
(2007)
Cancer
, vol.109
, pp. 221-227
-
-
Goff, B.A.1
Mandel, L.S.2
Drescher, C.W.3
Urban, N.4
Gough, S.5
Schurman, K.M.6
-
11
-
-
0027521105
-
The adnexal mass: Benign or malignant? evaluation of a risk of malignancy index
-
Davies AP, Jacobs I, Woolas R, Fish A, Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 1993;100:927-31.
-
(1993)
Brj
, vol.100
, pp. 927-931
-
-
Davies, A.P.1
Jacobs, I.2
Woolas, R.3
Fish, A.4
Oram, D.5
-
12
-
-
56749173383
-
A longitudinal investigation of psychological morbidity in patients with ovarian cancer
-
Goncalves V, Jayson G, Tarrier N. A longitudinal investigation of psychological morbidity in patients with ovarian cancer. Br J Cancer 2008;99:1794-801.
-
(2008)
Brj Cancer
, vol.99
, pp. 1794-1801
-
-
Goncalves, V.1
Jayson, G.2
Tarrier, N.3
-
13
-
-
84952775184
-
Cancer of the ovary
-
Pecorelli S, Ngan HYS, Hacker NF, editors, 3rd ed. London: International Federation of Gynecology and Obstetrics
-
Kavanagh JJ, Pecorelli S, Benedetti JL. Cancer of the ovary. In: Pecorelli S, Ngan HYS, Hacker NF, editors. Staging Classifications and Clinical Practice. Guidelines for Gynaecological Cancers. 3rd ed. London: International Federation of Gynecology and Obstetrics; 2000. p. 95-121.
-
(2000)
Staging Classifications and Clinical Practice. Guidelines for Gynaecological Cancers
, pp. 95-121
-
-
Kavanagh, J.J.1
Pecorelli, S.2
Benedetti, J.L.3
-
14
-
-
66849097259
-
Current figo staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia
-
Kavanagh JJ, Pecorelli S, Benedetti JL. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynecol Obstet 2009;105:3-4.
-
(2009)
Int J Gynecol
, vol.105
, pp. 3-4
-
-
Kavanagh, J.J.1
Pecorelli, S.2
Benedetti, J.L.3
-
15
-
-
0016586897
-
Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
-
Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975;42:101-4.
-
(1975)
Natl Cancer Inst Monogr
, vol.42
, pp. 101-104
-
-
Griffiths, C.T.1
-
16
-
-
0036498788
-
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
-
Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1248-1259
-
-
Bristow, R.E.1
Tomacruz, R.S.2
Armstrong, D.K.3
Trimble, E.L.4
Montz, F.J.5
-
17
-
-
34548491626
-
Prognostic factors for stage iii epithelial ovarian cancer: A gynecologic oncology group study
-
Winter WE III, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25:3621-7.
-
(2007)
J Clin Oncol
, vol.25
, pp. 3621-3627
-
-
Winter, W.1
Maxwell, G.L.2
Tian, C.3
Carlson, J.W.4
Ozols, R.F.5
Rose, P.G.6
-
18
-
-
38649086712
-
The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer
-
Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Aghajanian C, Barakat RR, Chi DS. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol 2008;108:276-81.
-
(2008)
Gynecol Oncol
, vol.108
, pp. 276-281
-
-
Eisenhauer, E.L.1
Abu-Rustum, N.R.2
Sonoda, Y.3
Aghajanian, C.4
Barakat, R.R.5
Chi, D.S.6
-
19
-
-
37849025830
-
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage iv epithelial ovarian cancer: A gynecologic oncology group study
-
Winter WE III, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG, et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2008;26:83-9.
-
(2008)
J Clin Oncol
, vol.26
, pp. 83-89
-
-
Winter, W.1
Maxwell, G.L.2
Tian, C.3
Sundborg, M.J.4
Rose, G.S.5
Rose, P.G.6
-
20
-
-
0041622805
-
Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: A prospective study
-
Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003;90:390-6.
-
(2003)
Gynecol Oncol
, vol.90
, pp. 390-396
-
-
Eisenkop, S.M.1
Spirtos, N.M.2
Friedman, R.L.3
Lin, W.C.4
Pisani, A.L.5
Perticucci, S.6
-
21
-
-
0032077205
-
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study
-
Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 1998;69:103-8.
-
(1998)
Gynecol Oncol
, vol.69
, pp. 103-108
-
-
Eisenkop, S.M.1
Friedman, R.L.2
Wang, H.J.3
-
22
-
-
34548140650
-
Multivisceral cytoreductive surgery in figo stages iiic and iv epithelial ovarian cancer: Results and 5-year follow-up
-
Scholz HS, Tasdemir H, Hunlich T, Turnwald W, Both A, Egger H. Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: results and 5-year follow-up. Gynecol Oncol 2007;106:591-5.
-
(2007)
Gynecol Oncol
, vol.106
, pp. 591-595
-
-
Scholz, H.S.1
Tasdemir, H.2
Hunlich, T.3
Turnwald, W.4
Both, A.5
Egger, H.6
-
23
-
-
20244376152
-
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial
-
Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 2005;97:560-6.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 560-566
-
-
Panici, P.B.1
Maggioni, A.2
Hacker, N.3
Landoni, F.4
Ackermann, S.5
Campagnutta, E.6
-
24
-
-
67650874081
-
Cancer statistics, 2009
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics, 2009. CA Cancer J Clin 2009;59:225-49.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
25
-
-
0028276411
-
Intervention debulking surgery in advanced epithelial ovarian cancer
-
Redman CW, Warwick J, Luesley DM, Varma R, Lawton FG, Blackledge GR. Intervention debulking surgery in advanced epithelial ovarian cancer. Br J Obstet Gynaecol 1994;101:142-6.
-
(1994)
Br J
, vol.101
, pp. 142-146
-
-
Redman, C.W.1
Warwick, J.2
Luesley, D.M.3
Varma, R.4
Lawton, F.G.5
Blackledge, G.R.6
-
26
-
-
0028952438
-
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the european organization for research and treatment of cancer
-
van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995;332:629-34.
-
(1995)
Nengl J Med
, vol.332
, pp. 629-634
-
-
Van Der Burg, M.E.1
Van Lent, M.2
Buyse, M.3
Kobierska, A.4
Colombo, N.5
Favalli, G.6
-
27
-
-
19744365355
-
Secondary surgical cytoreduction for advanced ovarian carcinoma
-
Rose PG, Nerenstone S, Brady MF, Clarke-Pearson D, Olt G, Rubin SC, et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 2004;351:2489-97.
-
(2004)
N Engl J Med
, vol.351
, pp. 2489-2497
-
-
Rose, P.G.1
Nerenstone, S.2
Brady, M.F.3
Clarke-Pearson, D.4
Olt, G.5
Rubin, S.C.6
-
28
-
-
57649183685
-
Interval debulking surgery for advanced epithelial ovarian cancer: A cochrane systematic review
-
Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P. Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review. Gynecol Oncol 2009 Jan;112(1):257-64.
-
(2009)
Gynecol Oncol
, vol.112
, Issue.1
, pp. 257-264
-
-
Tangjitgamol, S.1
Manusirivithaya, S.2
Laopaiboon, M.3
Lumbiganon, P.4
-
29
-
-
67651158840
-
Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review
-
Gerestein CG, Damhuis RA, Burger CW, Kooi GS. Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review. Gynecol Oncol 2009;114:523-7.
-
(2009)
Gynecol Oncol
, vol.114
, pp. 523-527
-
-
Gerestein, C.G.1
Damhuis, R.A.2
Burger, C.W.3
Kooi, G.S.4
-
32
-
-
0037440317
-
International collaborative ovarian neoplasm trial 1: A randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer
-
Colombo N, Guthrie D, Chiari S, Parmar M, Qian W, Swart AM, et al. International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 2003;95:125-32.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 125-132
-
-
Colombo, N.1
Guthrie, D.2
Chiari, S.3
Parmar, M.4
Qian, W.5
Swart, A.M.6
-
33
-
-
0037440295
-
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer adjuvant chemotherapy in ovarian neoplasm trial
-
Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003;95:113-25.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 113-125
-
-
Trimbos, J.B.1
Vergote, I.2
Bolis, G.3
Vermorken, J.B.4
Mangioni, C.5
Madronal, C.6
-
34
-
-
0037440207
-
International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: Two parallel randomized phase iii trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma
-
Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95:105-12.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 105-112
-
-
Trimbos, J.B.1
Parmar, M.2
Vergote, I.3
Guthrie, D.4
Bolis, G.5
Colombo, N.6
-
36
-
-
0035915662
-
Prognostic importance of degree of differentiation and cyst rupture in stage i invasive epithelial ovarian carcinoma
-
Vergote I, De BJ, Fyles A, Bertelsen K, Einhorn N, Sevelda P, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357:176-82.
-
(2001)
Lancet
, vol.357
, pp. 176-182
-
-
Vergote, I.1
De, B.J.2
Fyles, A.3
Bertelsen, K.4
Einhorn, N.5
Sevelda, P.6
-
37
-
-
0030054309
-
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage iii and stage iv ovarian cancer
-
McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
-
(1996)
Nengl J Med
, vol.334
, pp. 1-6
-
-
McGuire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
Kucera, P.R.4
Partridge, E.E.5
Look, K.Y.6
-
38
-
-
0034600305
-
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin- cyclophosphamide in women with advanced epithelial ovarian cancer: Three- year results
-
Piccart MJ, Bertelsen K, James K, Cassidy J, Mangioni C, Simonsen E, et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin- cyclophosphamide in women with advanced epithelial ovarian cancer: three- year results. J Natl Cancer Inst 2000;92:699-708.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 699-708
-
-
Piccart, M.J.1
Bertelsen, K.2
James, K.3
Cassidy, J.4
Mangioni, C.5
Simonsen, E.6
-
39
-
-
33645781536
-
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: A systematic review and economic evaluation
-
Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, et al. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. Health Technol Assess 2006;10(9):1-132.
-
(2006)
Health Technol Assess
, vol.10
, Issue.9
, pp. 1-132
-
-
Main, C.1
Bojke, L.2
Griffin, S.3
Norman, G.4
Barbieri, M.5
Mather, L.6
-
40
-
-
30044438368
-
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
-
Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354:34-43.
-
(2006)
N Engl J Med
, vol.354
, pp. 34-43
-
-
Armstrong, D.K.1
Bundy, B.2
Wenzel, L.3
Huang, H.Q.4
Baergen, R.5
Lele, S.6
-
41
-
-
0037862963
-
Paclitaxel plus platinum-based chemotherapy versus conventional platinum- based chemotherapy in women with relapsed ovarian cancer: The icon4/ago- ovar-2.2 trial
-
Parmar MK, Ledermann JA, Colombo N, du BA, Delaloye JF, Kristensen GB, et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum- based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO- OVAR-2.2 trial. Lancet 2003;361:2099-106.
-
(2003)
Lancet
, vol.361
, pp. 2099-2106
-
-
Parmar, M.K.1
Ledermann, J.A.2
Colombo, N.3
Du, B.A.4
Delaloye, J.F.5
Kristensen, G.B.6
-
42
-
-
33845657404
-
Surgery in recurrent ovarian cancer: The arbeitsgemeinschaft gynaekologische onkologie (ago) desktop ovar trial
-
Harter P, du Bois A, Hahmann M, Hasenburg A, Burges A, Loibl S, et al. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol 2006;13:1702-10.
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 1702-1710
-
-
Harter, P.1
Du Bois, A.2
Hahmann, M.3
Hasenburg, A.4
Burges, A.5
Loibl, S.6
-
43
-
-
32944467790
-
Laparoscopy versus laparotomy for benign ovarian tumour
-
Medeiros LR, Rosa DD, Bozzetti MC, Fachel JM, Furness S, Garry R, et al. Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database Syst Rev 2009;(2):CD004751.
-
(2009)
Cochrane
, Issue.2
-
-
Medeiros, L.R.1
Rosa, D.D.2
Bozzetti, M.C.3
Fachel, J.M.4
Furness, S.5
Garry, R.6
-
44
-
-
0029961618
-
Defining response of ovarian carcinoma to initial chemotherapy according to serum ca 125
-
Rustin GJ, Nelstrop AE, McClean P, Brady MF, McGuire WP, Hoskins WJ, et al. Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol 1996;14:1545-51.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1545-1551
-
-
Rustin, G.J.1
Nelstrop, A.E.2
McClean, P.3
Brady, M.F.4
McGuire, W.P.5
Hoskins, W.J.6
-
45
-
-
0029910164
-
Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature
-
Bristow RE, Lagasse LD, Karlan BY. Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature. Cancer 1996;78:2049-62.
-
(1996)
Cancer
, vol.78
, pp. 2049-2062
-
-
Bristow, R.E.1
Lagasse, L.D.2
Karlan, B.Y.3
-
46
-
-
33645329606
-
Routine follow-up after treatment for a gynecological cancer: A survey of practice
-
Kew FM, Cruickshank DJ. Routine follow-up after treatment for a gynecological cancer: a survey of practice. Int J Gynecol Cancer 2006;16:380-4.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 380-384
-
-
Kew, F.M.1
Cruickshank, D.J.2
-
47
-
-
68749099837
-
A randomized trial in ovarian cancer (Oc) of early treatment of relapse based on ca125level alone versus delayed treatment based on conventional clinical indicators (mrc ov05/eortc 55955 trials)
-
Rustin GJ, van der Burg ME, on behalf of MRC and EORTC collaborators. A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials). Int J Clin Oncol 2009;27 Suppl:18.
-
(2009)
Int J Clin Oncol
, pp. 18
-
-
Rustin, G.J.1
Van Der Burg, M.E.2
-
48
-
-
0037162115
-
Risk-reducing salpingo-oophorectomy in women with a brca1 or brca2 mutation
-
Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-15.
-
(2002)
N Engl J Med
, vol.346
, pp. 1609-1615
-
-
Kauff, N.D.1
Satagopan, J.M.2
Robson, M.E.3
Scheuer, L.4
Hensley, M.5
Hudis, C.A.6
-
49
-
-
63149087256
-
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the uk collaborative trial of ovarian cancer screening (ukctocs)
-
Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009;10:327-40.
-
(2009)
Lancet Oncol
, vol.10
, pp. 327-340
-
-
Menon, U.1
Gentry-Maharaj, A.2
Hallett, R.3
Ryan, A.4
Burnell, M.5
Sharma, A.6
|